week 2 of glp 1 Physiologic effects GLP-1 (adapted from Granata et al. [11]) Week 2 is here 😊

If your metabolism is a bit slower, you might need them more often

GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand Rhea-AI Summary Lexaria Bioscience (NASDAQ:LEXX) reports on accelerating GLP-1 adoption and expanding indications for obesity, diabetes and related diseases

In total, 7187 (9.8%) participants had a major adverse cardiovascular event, including 268 (3.7%) who were receiving GLP-1 receptor agonist and 6919 (96.3%) who were not receiving a GLP-1 receptor agonist at baseline

While this is a good starting point for most people, it's important to listen to your body and take breaks if you feel uncomfortable

The rate of infusion does not appear to affect the degree or duration of pain relief